Elinzanetant for Vasomotor symptoms [ID6544]

  • Awaiting development
  • GID-TA11784
  • Expected publication date: 
To appraise the clinical and cost effectiveness of Elinzanetant within its marketing authorisation for treating vasomotor symptoms ID6544